|
|
| |
New Gout Drugs ??? Pegloticase Continues Its Hopeful Path
In May 2008 the U.S. based company developing Pegloticase made another upbeat statement assessment of what they have learnt in its Phase 3 and open label extension trials. Note that Pegloticase still awaits approval from medical authorities so I am writing here about a new gout drug that is still under development.
This suggests that progression of the disease may be contained in difficult-to-treat cases, and therefore may not cause other medical conditions such as kidney stones heart disease and hypertension.
 |
60-Day Risk FREE Trial
People Said About Goutezol Gout Remedy
| "I was only 30 when I got a gout attack. Goutezol really helped me to get over the attack in just two days and the ebook helps me with watching what I'm eating. My uncle have had gout problems too, so I recommended your product. Thanks a lot!" Matt, California |
 |
SIDE EFFECTS Of course Pegloticase has caused side effects, in the extension trial in about 1 in 5 patients. The developing company has said that most were mild, moderate, or controllable. But in some cases more severe side effects have been described as including chest and back pains, muscle cramps, sweating and flushes.
TRIAL SUCCESS WITH DIFFICULT TO TREAT GOUT PATIENTS Pegloticase is significant because its trials have focused on gout patients who have not had success with other gout drugs, or who have medical conditions which prohibit the use of them. Thus it has been tackling harder-to-treat gout cases, not the easier ones. Hard to treat cases are a significant percentage of the gout sufferer universe. It was at the spur of the moment that we ventured to write something about kidney stone surgical procedures. Such is the amount of matter that is available on kidney stone surgical procedures.
Pegloticase is getting closer to an application for approval by the U.S. FDA. Its developers hope to apply for a Biologics Licence Application in September 2008, and begin marketing it in 2009. We have written a humorous anecdote on kidney stone surgical procedures to make it's reading more enjoyable and interesting to you. This way you learn there is a funny side to kidney stone surgical procedures too!
It has been having a decent degree of success. Elimination of gout attacks In its most recent statement the developing company's most significant remark was that the extension trial group receiving Pegloticase every two weeks, there were only four gout attacks among those who had been administered Pegloticase (8 mg) every fortnight for two months, in subsequent months. And none in this group had a gout attack after five months of Pegloticase treatment, in following months. All were patients who had been through a phase 3 trial. We were furnished with so many points to include while writing about kidney stone surgical procedures that we were actually lost as to which to use and which to discard!
In the world of natural gout remedies, uric acid's removal can be improved by making it more soluble. This is achieved by drinking lots of water and by raising body pH levels in various ways. The results of one reading this composition is a good understanding on the topic of kidney stone surgical procedures. So do go ahead and read this to learn more about kidney stone surgical procedures.
|
|
100% Natural and Safe Remedy
People Said About Goutezol Gout Treatment
| "week ago i couldnt walk and was in terible pain. i though my big toe was broken i would need a surgery, but doctor said it was gout. After taking some pain killer and goutezol for 2 days i can walk again. thank you" Peter from Chicago |
|
31% of patients who had not reduced tophi at the end of these phase 3 trials did show tophi reduction in the extension trial. It would seem that the longer a gout sufferer is able to take Pegloticase the more successful it may be, in tophi cases at least. Sometimes, what we hear about kidney stone surgical procedures can prove to be rather hilarious and illogical. This is why we have introduced this side of kidney stone surgical procedures to you.
May was a good month for gout sufferers. Febuxostat, (EU trade/brand name Adenuric), the first new major drug medication for gout in over 40 years, was approved for marketing in member countries of the European Union.
Pegloticase's answer to the excess uric acid level problem is to remove it by ingeniously converting uric acid into something else, a substance called Allantoin. Allantoin is more soluble and better excreted than uric acid. The principle comes from the way most animals do it. They do it by converting UA to Allantoin, but this is something humans cannot do naturally. Hence the formulation of Pegloticase. Writing an article on kidney stone surgical procedures was our foremost priority while thinking of a topic to write on. This is because kidney stone surgical procedures are interesting parts of our lives, and are needed by us.
HOW PEGLOTICASE WORKS What makes Pegloticase a very interesting, and more importantly, a hopeful new gout drug, is the way it works. All drugs used in gout try to cure or alleviate the disease by reducing the body's uric acid (UA) levels. They do this by either inhibiting its production or making it easier to remove. Remember that it is very important to have a disciplined mode of writing when writing. This is because it is difficult to complete something started if there is no discipline in writing especially when writing on kidney stone surgical procedures
In other patient groups there were reductions in attacks and improvement in tophi reduction. Tophi are those knobbly shaped, awkward looking, lumps of MSU crystals that often develop in longer term gout sufferers.
NB. The contents of this article contain medical information not medical advice. Please always discuss gout remedies with your doctor or other health care professional, before implementing any treatment.
|
|
|
|
| |
| |
|
|
|
|
|
|
| |
| |
Learn More about Natural Gout Remedy
It has taken a very long time for a major new gout drug to be developed and approved. Probably the best gout news in over 40 years, is that Febuxostat, which has been given the trade/brand name of Adenuric, has been approved by the European Medicines Agency for marketing in European Union (EU) countries.
This approval applies only to EU countries. Febuxostat has not yet been approved in... 
Gout is one of the most common forms of arthritis (joint inflammation). Gout is condition that results from crystals of uric acid depositing in tissues of the body. Gout usually affects the first metatarsal phalangeal joint of the big toe (hallux) or the ankle joints. Gout most often affects the big toe but can also affect the ankle, knee, foot, hand, wrist and elbow. Approximately one million...
There seems that there is a lot of confusion as to what gout arthritis, or gouty arthritis, is because so many
people just think that arthritis is arthritis and that all types are the same. But that is simply not the case at
all as gout arthritis is very different from other types of arthritis. This type of arthritis is a sudden attack of
extreme pain within the...
Obesity is because of eating too many calories and not getting enough physical activities to burn those calories. Excess calories are deposited in the body as fat.
Obesity increases the risk of several health problems like high blood pressure, insulin resistance, type 2 diabetes, heart diseases, stroke, gout, gallstones, colon cancer, sleep apnea and non-alcoholic fatty liver disease. ...
People always have the mentality that as long as one does not eat junk food, one can be considered to have a healthy diet. Actually a diet that is considered healthy to one might be unhealthy to another person, it can be quite subjective in this context. Gout patients are usually advice to go on a special diet, which will help to alleviate the pain cause by gout attacks. This diet will require...
over the counter drugs for gout | gout hyperuricemia joint symptom | calcium phosphate kidney stones | kidney stone surgical procedures | what are the treatments for gout | gout treatment causes prevention |
|
|
|
| |
| |
|
|
| |
|
|
|
|
